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A B S T R A C T
Purpose.: To determine safety and efﬁcacy of hyperventilation (HV) during electroencephalography
(EEG).
Methods: We report the ﬁndings of a prospective multicentre National Service Evaluation of the
occurrence of adverse events, seizures and interictal epileptiform discharges seen in association with HV
during EEG, in a relatively unselected, largely out patient population of 3475 being investigated
predominantly for possible epileptic seizures.
Results: Adverse events occurred rarely, and there were no reported signiﬁcant cerebrovascular,
cardiovascular or respiratory events. Of the 3170 patients suspected of ‘epilepsy or possible epilepsy’ 69
patients (2.2%) had seizures provoked by HV, but only one (0.03%) had a generalised tonic clonic seizure.
The elicitation or increase of interictal epileptiform discharges (IEDs) was seen in 387 (12.2%) of the total
3170 patients with suspected epilepsy who hyperventilated. Furthermore 31 patients (0.9%) had
psychogenic non-epileptic seizures.
Conclusion: HV is rarely associated with adverse events, but contributes to the diagnosis and
classiﬁcation of seizure disorders in an appreciable proportion of patients with epilepsy and non-
epileptic attacks. These ﬁndings conﬁrm that HV in selected patients is a valid activation technique in
diagnostic EEG, where the potential beneﬁts out weigh the risks, and also provide information that may
assist the informed consent process.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Voluntary hyperventilation (HV) was known to provoke
epileptic seizures1,2 prior to the advent of electroencephalography
(EEG) as a clinical investigation. It is no surprise then that HV
provided the ﬁrst EEG ‘activation procedure’.3 However, in spite of
its widespread use, surprisingly little is known about the risk of
adverse events during voluntary HV, the incidence of epileptic
seizure provocation, and its diagnostic efﬁcacy in terms of eliciting
or increasing interictal epileptiform discharges (IEDs). There is a
single centre retrospective analysis reviewing 1000 EEG investiga-
tions, which gives some indication of the occurrence of both
seizures and IEDs during activation procedures.4 Twelve seizures
(2.1%) were reported occurring in the 580 relatively unselected
patients who were hyperventilated for 3 min, and an increase in
IEDs in another 60 of their patients (10.3%).4* Corresponding author. Tel.: +44 117 3403643; fax: +44 117 9186797.
E-mail addresses: Nick.Kane@nbt.nhs.uk, Nicholas.Kane@icloud.com (N. Kane).
1 On behalf of the Association of Neurophysiological Scientists and the British
Society for Clinical Neurophysiology.
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.10.010A review of the literature on HV as an activating procedure
noted that it is considerably more effective in generalised
epilepsies than in focal epilepsy syndromes.5 Indeed the early
exponents of HV identiﬁed that children with ‘petit mal epilepsy’
(Childhood Absence Epilepsy) were the most sensitive to its
effects; 77% of patients with that diagnosis (from 1107 with
epilepsy) had ‘‘three-per-second wave and spike pattern’’ in the
resting record, but an additional 8% were only revealed by over-
ventilation (HV).6 The role of HV in Childhood Absence Epilepsy
was secured by an extensive study which found that HV provoked
3 per second generalised spike and wave in 88% of 234 patients.7
What is less clear is how efﬁcacious it is in focal (or partial)
epilepsies, although it has recently been pointed out that because
focal IEDs, and sometimes seizures, can be activated by HV it
should not be neglected in patients with focal epilepsy.8 Early work
is confounded by the exact interpretation of paroxysmal abnor-
malities in the EEG during HV; but in the modern era rates of IED
activation have been reported between 6.6% of 255 patients and
3.4% of 383 patients, diagnosed with focal or partial epilepsy.9,10
However, the induction of partial seizures appears to be more
variable in patients diagnosed with focal epilepsies; with rates
ranging from either none in 159 patients11 or as low as 0.46%10 upvier Ltd. All rights reserved.
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epilepsies 17.5% of 80 patients12 and 24.7% of 97 patients13 had
seizures with repeated HV and anticonvulsant drug reduction in
patients during prolonged video EEG monitoring.
The American EEG Society (AEEGS, 2004),14 International
League Against Epilepsy15 and National Institute for Health and
Clinical Excellence (NICE, 2012)16 all recommend that HV is
performed as part of a standard EEG. The AEEGS provides
contraindications to HV including recent subarachnoid haemor-
rhage, intracranial haemorrhage, or signiﬁcant cardio-pulmonary
disease. NICE (CG 137) recommends that ‘‘the child, young person
or adult and family and/or carer should be made aware that such
activation procedures may induce a seizure and they have a right to
refuse’’. In order to provide informed consent it is necessary to
quantify these risks in an unselected population, reﬂecting actual
clinical referral practice, and to place them in the context of the
potential beneﬁts of increased diagnostic sensitivity of the
standard EEG. Patients should not only be advised of the risk of
epileptic seizures but also potential non-epileptic events, as well as
the likely positive outcomes in terms of diagnostic information.
Useful diagnostic information includes eliciting generalised
absence seizures, an increase in IEDs, and perhaps even
psychogenic non-epileptic seizures. This prospective multicentre
National Service Evaluation, organised by two professional
organisations in the UK (the Association of Neurophysiological
Scientists and the British Society for Clinical Neurophysiology),
attempts to address this relative deﬁciency in the EEG literature.
2. Methods and patients
In line with the UK NHS National Research Ethics Service’s
guidelines Ethical approval was not deemed necessary for this
service evaluation of routine clinical practice. However, all the
patients in this service evaluation were given informed consent
and provided with the option not to hyperventilate during their
EEG recording. Data was collected prospectively by the profes-
sionally trained recording Clinical Physiologist in 56 participating
UK Departments of Clinical Neurophysiology (see Acknowledge-
ment) from 6242 consecutive patients referred for a standard EEG
between beginning October and end December 2011 (see
Appendix: Questionnaire). A total of 3475 (56%) patients could
be hyperventilated, for periods ranging from 1 to 7 min (with a
median of 3 min in 83% of patients). Some 2767 (44%) did not
hyperventilate; either because it was against department protocol
(46%), the patient could not co-operate (29%), was too young (19%),
refused (1%), or some other reason not speciﬁcally deﬁned (5%).
There were 3129 females (50.1%) and 3113 males (49.9%) with
an age range of 3 months to 97 years (mean 33.1 years). In terms
of the provisional primary clinical diagnosis of those who0
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Fig. 1. Percentage hyperventilation activation of seizures and new interictal epileptiforhyperventilated 3170 patients (91%) were referred with ‘epilepsy
or possible epilepsy’, 102 (3%) with possible psychogenic non-
epileptic seizures, and 203 (6%) with some other diagnosis which
was not deﬁned.
Adverse Events are deﬁned by the General Medical Council as
‘‘any unintended or unexpected event which could or did lead to
harm of one or more patients’’. Such Events that were deemed to be
caused by or temporally associated with HV were identiﬁed by the
recording Clinical Physiologist, and classiﬁed as either a cardio-
vascular, respiratory or cerebrovascular event, a psychogenic non-
epileptic seizure or an epileptic seizure. Predictable side effects of
hyperventilation, such as dizziness, light headedness, paraesthe-
sias and headaches, were not recorded. Any activated epileptic
seizures were broadly classiﬁed by their electro-clinical char-
acteristics as either focal or generalised, with a clinical description
of seizure type where possible, along with spontaneous seizures
occurring during the resting record (i.e. not activated). In order to
determine efﬁcacy the recording Physiologist identiﬁed if HV
produced unequivocal epileptiform activity or IEDs (deﬁned as
‘sharp waves, spikes with or without slow waves’) not seen in the
resting record, or if HV exacerbated epileptiform activity seen in
the resting record. All the information was submitted anonymous-
ly into a Microsoft Access database to the Organising Committee
for analysis.
3. Results
Of the 3475 patients who were able and willing to HV there
were only two reported symptomatic cardiovascular, respiratory
or cerebrovascular adverse events. A known asthmatic complained
of wheeziness and a second patient experienced symptomatic
tachycardia (130 bpm from 100 bpm) during a non-epileptic
seizure, both of which were self-limiting and stopped on cessation
of HV. Non-epileptic attacks or psychogenic non-epileptic seizures
were reported in 31 patients (including ‘disorientation, jerks,
twitching, eyelid ﬂickering and other abnormal rhythmic move-
ments involving the limbs or torso’), where there were no
accompanying abnormal EEG changes.
Epileptic seizures were precipitated by HV in 69 patients (2.2%),
with 59 (85%) identiﬁed as generalised, 8 (12%) as focal, and 2 (3%)
as undetermined or unspeciﬁed. The 59 generalised seizures were
classiﬁed as absences in 54, generalised tonic clonic seizure in 1,
eyelid myoclonia in 1 and not speciﬁed in 3. The mean age of
patients with generalised seizures was 10.3 years (range 3–33
years), and 29 (54%) of these patients had spontaneous seizures (all
absences) during the resting record as well (i.e. not activated). This
suggests that HV gives a nearly twofold increase in generalised
absence seizures (although of course HV typically only accounts for
around 3 min of a standard 20 min recording). The 8 focal seizures to 60 61  to 70 71  to 91
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(sensory) in 1 and not deﬁned in 1. The mean age of patients with
focal seizures was 36.5 years (range 10–55 years).
Of the 3170 with a pre-test clinical diagnosis of ‘epilepsy or
possible epilepsy’ interictal epileptiform activity not seen in the
resting record was reported in 95 patients (3.0%) and exacerbated
in another 292 patients (9.2%). This gives a combined yield of
12.2%, where HV may have contributed directly to a diagnosis of
epilepsy, lent support to it, and helped classify the seizure type. In
the 135 (3.9%) patients over 60 years of age there were no recorded
seizures or adverse events, but the overall yield of new IEDs and
exacerbation was comparable to that for adult patients between 21
and 60 years (see Fig. 1).
4. Discussion
The ﬁndings of this multicentre service evaluation give some
indication of the incidence of adverse events, non-epileptic
episodes or psychogenic non-epileptic seizures, epileptic seizures
and interictal diagnostic information that may be elicited by HV
during a standard EEG in an unselected population of patients,
predominantly suspected of having had seizures. The two adverse
symptomatic events in this population were relatively minor and
without sequelae; both HV-induced tachycardia and broncho-
spasm in asthma are known to occur.17 Careful selection of
patients, through the use of departmental protocols, may have
contributed to this low complication rate. There are case reports in
the literature of HV precipitating death in a patient with cardio-
respiratory disease,18 myocardial infarction both without19 and
with20 known coronary artery disease, apnoea in a patient with
hypoxaemia21 and even asystole with syncope in healthy
athletes.22 Whilst these may be rare adverse events, for the most
part in patients with pre-existing medical conditions, there is little
room for complacency and a need for clear guidelines. Indeed there
are clinical situations where HV is best avoided all together,
particularly when there is a risk of cerebral vasospasm-induced
transient ischaemic attack or stroke, a recognised complication of
HV in patients with sickle cell and moyamoya disease.23,24 Even
though the EEG ‘rebuild-up’ (slow wave) response after cessation
of HV can be diagnostic in moyamoya disease,25 it seems prudent
to omit HV in known cases. For similar reasons it is sensible to
avoid HV in patients with known recent cerebrovascular events
(including cerebral infarction, subarachnoid and intracerebral
haemorrhage) and signiﬁcant coronary artery disease, as recom-
mended by the AEEGS (2004).14
This service evaluation did not intentionally set out to
investigate psychogenic non-epileptic seizures (PNES), although
31 PNES were reported in association with HV (usually consisting
of signiﬁcant motor symptoms without concomitant epileptiform
EEG changes). Some of these were described as habitual by the
patients, and in the 102 patients referred with a provisional
diagnosis of PNES who performed HV12 (11.8%) had such typical
attacks during HV. In one study HV provoked PNES in as many as 16
of 19 (84%) patients with suspected PNES, and in another
randomised controlled trial of 30 patients HV ‘with suggestion’
doubled the yield of PNES (as compared to ‘without suggestion’),
leading these authors to suggest a role for the cost effective
outpatient EEG conﬁrmation of PNES using HV.26,27 On the other
hand, NICE (CG 137, 2012) states that provocation ‘‘has a limited
role and may lead to false-positive results in some people’’.16 It is
possible that some patients may be incorrectly diagnosed with
PNES, for example several of the patients in our survey experienced
‘disorientation and twitching’ (that could be due to tetany), which
are recognised neurological manifestations of the ‘hyperventila-
tion syndrome’.28,29 Overall our ﬁndings do lend support to the use
of hyperventilation during EEG as a cost effective and efﬁcaciousway of screening for PNES, as suggested by others, 26,27 when
compared to the more costly standard prolonged ambulatory EEG
recording over several days.
Of the 3170 with a pre-test clinical diagnosis of ‘epilepsy or
possible epilepsy’ 69 patients (2.2%) had seizures evoked by HV,
which is virtually identical to the 2.1% of the single centre
retrospective review of 580 patients who hyperventilated.4 This
then would appear to provide a reasonable estimate of the number
of seizures that can be expected in a relatively unselected out
patient population, referred for a diagnostic EEG when epilepsy is
suspected. This could therefore form the basis for informing
patients of the seizure risk associated with HV, as part of the
consent process. Whilst no seizure should be viewed as risk free, or
without potential adverse consequence (e.g. loss of driving
licence), it is worth bearing in mind that in our survey the vast
majority were generalised absences in children without any
apparent sequelae. Indeed provocation of this seizure type is the
intention of HV during a diagnostic EEG, and does not pose a
signiﬁcant risk to the child. There was in fact only one unexpected
generalised tonic clonic seizure in our survey (0.03%). The
proportion of our patients having focal seizures was much less
than those having generalised seizures, with only 8 (0.25%)
occurring in association with HV; although we do not know the
overall proportion of patients classiﬁed clinically as having either
generalised or focal seizure syndromes. None the less our ﬁndings
lend support to the observation that both focal IEDs and seizures
can be activated by HV,8 and can therefore be contributory in
patients with focal epilepsies, backed up by a number of case
reports in the literature.1,2,30,31 The incidence of focal or partial
seizures in published series ranges from none11 up to 24.7%13;
although this appears to be inﬂuenced by the intractability of the
seizure disorder, anticonvulsant drug reduction, and duration of
both the EEG recording and HV itself. One prospective study
calculated that the rate of seizure induction by HV was almost six
times more than without it, in 54 patients with medically
intractable localisation-related epilepsy,32 where HV may have a
speciﬁc diagnostic role.
The elicitation or increase of interictal epileptiform discharges
(IEDs) was seen in 387 (12.2%) of the 3170 patients with possible
epilepsy who hyperventilated, which is also similar to the 10.3%
reported in the single centre study.4 Once again this would appear
to give a reasonable approximation of the potential diagnostic
beneﬁt when counselling patients on the role of HV during a
standard EEG, in a relatively unselected out-patient population
when seizures are suspected. Most other series publish marginally
higher rates of ‘new IEDs’ during HV than our ﬁgure of only 3.0%,
where this adds unique diagnostic information not seen in the
resting record. For example, one group reported localised
abnormalities in 13 (8.1%) of 161 and generalised abnormalities
in 15 (6.7%) of 223 patients,33 another found spikes in 17 (6.6%) of
255 patients,9 and a third saw IEDs in 3 (5.5%) of 55 patients.34
However, it should be borne in mind that these activation rates are
reported from patient populations who carry a clinical diagnosis of
deﬁnite epilepsy, in contrast to our own who may only have been
suspected of having had an epileptic seizure. It is clear that the type
of epilepsy and its severity may also have a bearing on the yield
from HV; for example, in small series (of <100 patients), 22% in
juvenile myoclonic epilepsy,35 31% in symptomatic secondary
generalised epilepsy,36 and over 50% in the ‘malignant’ Lennox–
Gastaut syndrome.37 Whilst it is difﬁcult therefore to generalise
based on different patient populations it is clear that HV does
indeed add valuable diagnostic information, which cannot be
obtained in short standard EEG recordings alone. This information
can help with the early diagnosis and appropriate treatment of the
epilepsies, in the hope of reducing seizure related injuries and
sudden unexplained death in epilepsy. We have not discussed the
N. Kane et al. / Seizure 23 (2014) 129–134132role of other standard activation techniques, namely photic
stimulation, sleep deprivation and sleep; but we are about to
embark on a similar prospective multicentre study of both photic
stimulation and sleep deprivation versus melatonin induced sleep
to address this.
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Postcode  of Cen tre
(Please  complete)
Project  Code 
(Do not  complete . Fo
1.  What  is the age of the patient?
2.  What  is the gender of the patie nt?
3.  What  was  the referral  dia gnosis? 
4.  Was  hyperventilati on performed?
If “Yes” go  to que stion  6 and continue qu estionnaire
If “No”  answer  question  5 only
5.  Why was hyperventilati on not  performed? 
6.  Was t here a significa nt  clinical  change during HV?
Do not incl ude  common eff ects of  HV e.g. dizziness /light  he aded n
If "N o"  go to questi on  11
7.  If “Yes” was it:
If  no  epilepti c sei zure o ccurred  go to questi on  11. 
If  an  epi lep tic  sei zure  di d occur ple ase answer questions 8, 9 and 
8. I f an epile ptic  seiz ure  was precipitate d by HV , was it: 
9. Can you  be precise about seiz ure type e.g. Absence, Myocl onic   
Please  describe.
10. Di d simila r seiz ures occur  in the resti ng record? 
11. Di d hyperventil ati on produce unequivocal  epil epti form inte rictal 
EEG acti vity NOT seen in the resting record? (i. e. sharp  waves /spike
with or wit hout sl ow waves.)
12. Di d hyperventil ati on exacerbate  epile pti form activity previously 
seen in the resti ng record? 
13. For how long was hyperventilati on performed (to neares t minute )
14. Was HV  well  performed?                 
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